Merck KGaA sees forex-adjusted earnings growth of up to 8% this year
Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced ...
New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle
The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.
New version of Merck's Keytruda faces possible patent battle, WSJ reports
Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...
Merck (MRK) Battling to Protect Key Cancer Drug as Patent Row Heats Up
Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a ...
New version of Merck's cancer drug faces possible patent battle, WSJ reports
Biotech Halozyme Therapeutics believes the new version of Merck's blockbuster cancer drug Keytruda infringes on its patents, ...
Fierce Pharma2h
In patent clash over injectable Keytruda, Merck and Halozyme dig in for a fight
Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...
Merck & Co. Inc. stock outperforms competitors on strong trading day
Merck & Co. Inc. closed 32.72% below its 52-week high of $134.63, which the company achieved on June 25th.
Fierce Biotech6h
Merck KGaA fails midphase lupus trial, says totality of data support further development
One of Merck KGaA’s leading immunology assets has flunked a phase 2 lupus trial. | One of Merck KGaA’s leading immunology ...
Merck KGaA (MKGAF) Q4 2024 Earnings Call Transcript
Q4 2024 Results Conference Call March 6, 2025 8:00 AM ETCompany ParticipantsFlorian Schraeder - Head of Investor ...
Delaware approves $30.2 million taxpayer-funded grant for Merck to build in state
The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...